Dr. Riti Chhibba, OD

NPI: 1033603972
Total Payments
$2,570
2024 Payments
$642.86
Companies
17
Transactions
47
Medicare Patients
209
Medicare Billing
$9,815

Payment Breakdown by Category

Food & Beverage$2,570 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $2,570 47 100.0%

Top Paying Companies

Company Total Records Latest Year
Allergan, Inc. $610.49 9 $0 (2022)
Bausch & Lomb Americas Inc. $322.27 9 $0 (2024)
Novartis Pharmaceuticals Corporation $315.99 5 $0 (2022)
Horizon Therapeutics plc $309.42 4 $0 (2023)
Amgen Inc. $173.25 3 $0 (2024)
Eyevance Pharmaceuticals LLC $150.00 1 $0 (2021)
Tarsus Pharmaceuticals, Inc. $128.14 1 $0 (2024)
Carl Zeiss Meditec, Inc. $86.67 1 $0 (2019)
Johnson & Johnson Vision Care, Inc. $79.54 1 $0 (2022)
ABBVIE INC. $78.62 3 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $642.86 15 Bausch & Lomb Americas Inc. ($198.18)
2023 $439.68 7 Horizon Therapeutics plc ($309.42)
2022 $397.28 10 Allergan, Inc. ($139.46)
2021 $576.78 7 Allergan, Inc. ($426.78)
2020 $40.47 2 Bausch & Lomb, a division of Bausch Health US, LLC ($40.47)
2019 $332.89 5 Novartis Pharmaceuticals Corporation ($132.36)
2018 $140.53 1 Novartis Pharmaceuticals Corporation ($140.53)

All Payment Transactions

47 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
12/04/2024 Bausch & Lomb Americas Inc. MIEBO (Drug) Food and Beverage In-kind items and services $59.91 General
Category: Ophthalmology
11/13/2024 Tarsus Pharmaceuticals, Inc. XDEMVY (Drug) Food and Beverage In-kind items and services $128.14 General
Category: DEMODEX BLEPHARITIS
11/01/2024 SUN PHARMACEUTICAL INDUSTRIES INC. Cequa (Drug) Food and Beverage In-kind items and services $35.59 General
Category: Ophthalmology
10/21/2024 ABBVIE INC. LUMIGAN (Drug) Food and Beverage In-kind items and services $30.65 General
Category: EYE CARE
10/15/2024 Amgen Inc. TEPEZZA (Biological) Food and Beverage In-kind items and services $125.00 General
Category: Inflammation/Rare Disease
07/31/2024 Bausch & Lomb Americas Inc. MIEBO (Drug), XIIDRA Food and Beverage In-kind items and services $60.26 General
Category: Ophthalmology
07/11/2024 Amgen Inc. TEPEZZA (Biological) Food and Beverage In-kind items and services $22.89 General
Category: Inflammation/Rare Disease
07/11/2024 Bausch & Lomb Americas Inc. MIEBO (Drug) Food and Beverage In-kind items and services $15.79 General
Category: Ophthalmology
06/10/2024 Bausch & Lomb Americas Inc. MIEBO (Drug) Food and Beverage In-kind items and services $24.39 General
Category: Ophthalmology
05/23/2024 Amgen Inc. TEPEZZA (Biological) Food and Beverage In-kind items and services $25.36 General
Category: Inflammation/Rare Disease
04/27/2024 CooperVision Inc. Ortho-K Contact Lens (Device) Food and Beverage In-kind items and services $53.00 General
Category: Devices
04/26/2024 Bausch & Lomb Americas Inc. XIIDRA (Drug), MIEBO Food and Beverage In-kind items and services $9.95 General
Category: Ophthalmology
04/12/2024 Bausch & Lomb Americas Inc. XIIDRA (Drug) Food and Beverage In-kind items and services $15.70 General
Category: Ophthalmology
03/05/2024 Astellas Pharma US Inc Izervay (Drug) Food and Beverage In-kind items and services $24.05 General
Category: Ophthalmology
01/29/2024 Bausch & Lomb Americas Inc. XIIDRA (Drug), MIEBO Food and Beverage In-kind items and services $12.18 General
Category: Ophthalmology
12/08/2023 Sun Pharmaceutical Industries Inc. Cequa (Drug) Food and Beverage In-kind items and services $13.90 General
Category: Ophthalmology
10/31/2023 Bausch & Lomb Americas Inc. XIIDRA (Drug) Food and Beverage In-kind items and services $101.87 General
Category: Ophthalmology
10/25/2023 Horizon Therapeutics plc TEPEZZA (Drug) Food and Beverage In-kind items and services $130.88 General
Category: TEPEZZA
09/22/2023 Horizon Therapeutics plc TEPEZZA (Drug) Food and Beverage In-kind items and services $24.32 General
Category: TEPEZZA
06/14/2023 Sun Pharmaceutical Industries Inc. Cequa (Drug) Food and Beverage In-kind items and services $14.49 General
Category: Ophthalmology
05/04/2023 Horizon Therapeutics plc TEPEZZA (Drug) Food and Beverage In-kind items and services $29.22 General
Category: TEPEZZA
02/28/2023 Horizon Therapeutics plc TEPEZZA (Drug) Food and Beverage In-kind items and services $125.00 General
Category: TEPEZZA
12/12/2022 Bausch & Lomb Americas Inc. VYZULTA (Drug), LOTEMAX SM Food and Beverage In-kind items and services $22.22 General
Category: Ophthalmology
12/08/2022 ABBVIE INC. LUMIGAN (Drug) Food and Beverage In-kind items and services $25.00 General
Category: OPHTHALMOLOGY
10/27/2022 Alcon Vision LLC Food and Beverage In-kind items and services $64.99 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 73 75 $25,968 $2,532
2022 3 49 53 $22,753 $2,371
2021 3 50 57 $28,090 $3,129
2020 2 37 41 $16,117 $1,783
Total Patients
209
Total Services
226
Medicare Billing
$9,815
Procedure Codes
12

All Medicare Procedures & Services

12 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
92012 Established patient problem focused exam of visual system Facility 2023 32 33 $13,337 $1,179 8.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2023 17 18 $7,058 $831.71 11.8%
92002 New patient problem focused exam of visual system Facility 2023 13 13 $4,783 $404.10 8.4%
92202 Extended exam of the back part of the eye with optic nerve drawing Facility 2023 11 11 $790.00 $117.54 14.9%
92012 Established patient problem focused exam of visual system Facility 2022 22 25 $10,725 $1,026 9.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2022 16 17 $7,463 $1,003 13.4%
92002 New patient problem focused exam of visual system Facility 2022 11 11 $4,565 $342.26 7.5%
99213 Established patient outpatient visit, total time 20-29 minutes Facility 2021 15 19 $8,352 $1,157 13.9%
92012 Eye and medical examination for diagnosis and treatment, established patient Facility 2021 23 26 $11,206 $1,095 9.8%
92004 Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits Facility 2021 12 12 $8,532 $876.40 10.3%
92012 Eye and medical examination for diagnosis and treatment, established patient Facility 2020 21 23 $9,637 $1,007 10.5%
99213 Established patient office or other outpatient visit, typically 15 minutes Facility 2020 16 18 $6,480 $775.88 12.0%

About Dr. Riti Chhibba, OD

Dr. Riti Chhibba, OD is a Optometrist healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2018. The National Provider Identifier (NPI) number assigned to this provider is 1033603972.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Riti Chhibba, OD has received a total of $2,570 in payments from pharmaceutical and medical device companies, with $642.86 received in 2024. These payments were reported across 47 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($2,570).

As a Medicare-enrolled provider, Chhibba has provided services to 209 Medicare beneficiaries, totaling 226 services with total Medicare billing of $9,815. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.

Practice Information

  • Specialty Optometrist
  • Location Bronx, NY
  • Active Since 06/14/2018
  • Last Updated 06/14/2018
  • Taxonomy Code 152W00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1033603972

Products in Payments

  • LUMIGAN (Drug) $358.94
  • TEPEZZA (Drug) $309.42
  • TRAVATAN Z (Drug) $272.89
  • XIIDRA (Drug) $182.80
  • TEPEZZA (Biological) $173.25
  • RESTASIS MULTIDOSE (Drug) $167.74
  • VUITY (Drug) $162.43
  • MIEBO (Drug) $160.35
  • Zerviate (Drug) $150.00
  • XDEMVY (Drug) $128.14
  • CIRRUS HD-OCT (Device) $86.67
  • Acuvue (Device) $79.54
  • Cequa (Drug) $63.98
  • Ortho-K Contact Lens (Device) $53.00
  • VYZULTA (Drug) $47.17
  • EYLEA (Biological) $35.90
  • Tecnis Multifocal Family of 1-piece IOLS (Device) $33.71
  • Izervay (Drug) $24.05
  • LOTEMAX SM (Drug) $15.52

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Optometrist Doctors in Bronx